Indication:? \nCavirTM?is indicated for the treatment of chronic hepatitis B virus infection in adults \nwith evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
\nDosage & Administration: \nCavirTM?should be administered on an empty stomach (at least 2 hours after a meal or 2 hours before the next meal). \nNucleoside-treatment-naive (16 years): 0.5 mg once daily. \nLamivudine-refractory or known lamivudine or Telbivudine resistance mutations (16 years): 1 mg once daily.
\nPreparation:? \nCavirTM?0.5 Tablet: Each box contains 10 tablets in Alu-Alu blister pack. \nCavirTM 1 Tablet: Each box contains 10 tablets in Alu-Alu blister pack.
\n \nYour purchase will delivered in 1 shipment
Your shopping bag is empty. Start shopping now.